| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |